Treatment of primary <it>g</it>lioblastoma multiforme with c<it>e</it>tuximab, <it>r</it>adiotherapy and <it>t</it>emozolomide (GERT) – phase I/II trial: study protocol
<p>Abstract</p> <p>Background</p> <p>The implementation of combined radiochemotherapy (RCHT) with temozolomide (TMZ) has lead to a significant increase in overall survival times in patients with Glioblastoma multiforme (GBM), however, outcome still remains unsatisfactor...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-05-01
|
| Series: | BMC Cancer |
| Online Access: | http://www.biomedcentral.com/1471-2407/6/133 |